Hypermarcas (OTCMKTS:HYPMY) Upgraded at Jefferies Financial Group

Jefferies Financial Group upgraded shares of Hypermarcas (OTCMKTS:HYPMY) to a strong-buy rating in a report published on Monday morning,Zacks.com reports.

Separately, Zacks Research upgraded Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy”.

Hypermarcas Price Performance

OTCMKTS:HYPMY opened at $4.00 on Monday. The firm has a market capitalization of $2.81 billion, a price-to-earnings ratio of 8.32 and a beta of 0.71. Hypermarcas has a one year low of $3.71 and a one year high of $5.50. The business has a fifty day moving average price of $4.17 and a 200-day moving average price of $4.38.

Hypermarcas (OTCMKTS:HYPMY) last announced its earnings results on Wednesday, April 29th. The company reported $0.10 EPS for the quarter. The company had revenue of $383.13 million for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%. On average, equities research analysts expect that Hypermarcas will post 0.53 earnings per share for the current fiscal year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.